Se connecter

Bibliographies thématiques / Virus diseases – Chemotherapy / Articles de revues

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Virus diseases – Chemotherapy.

Articles de revues sur le sujet « Virus diseases – Chemotherapy »

Auteur : Grafiati

Publié le 25 juillet 2024

Mis à jour le 31 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Virus diseases – Chemotherapy ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Talib Al-Nafakh, Rana. "Epstein–Barr Virus and Rheumatoid Arthritis in Cancer Patients Undergoing Chemotherapy in Al-Najaf Province, Iraq." Journal of Communicable Diseases 55, no. 04 (2024): 119–25. http://dx.doi.org/10.24321/0019.5138.202364.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Rollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 1. Feline Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 5 (1992): 249–62. http://dx.doi.org/10.1177/095632029200300501.

Texte intégral

Résumé :

This paper, which is published in two parts, reviews the literature pertaining to antiviral chemotherapy of viruses of veterinary importance. While early reports in the 1970s referred to the chemotherapy of a number of different RNA and DNA viruses, there was considerable focus in the 1980s, initially on herpesviruses and latterly on retroviruses, particularly in cats. Details are given of the successful treatments of FeLV and FIV, which have been used as animal models for HIV therapy. The high costs of developing and registering a new chemical entity, especially for food species, in which ext

Styles APA, Harvard, Vancouver, ISO, etc.

3

Snoeck, R., G. Andrei, and E. De Clercq. "Chemotherapy of varicella zoster virus infections." International Journal of Antimicrobial Agents 4, no. 3 (1994): 211–26. http://dx.doi.org/10.1016/0924-8579(94)90011-6.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Polsky, Bruce. "Antiviral Chemotherapy for Infection with Human Immunodeficiency Virus." Clinical Infectious Diseases 11, Supplement_7 (1989): S1648—S1663. http://dx.doi.org/10.1093/clinids/11.supplement_7.s1648.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Han, Seung Beom, Hye Jo Shin, Eui Soo Lee, et al. "SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA." Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (2019): e2019052. http://dx.doi.org/10.4084/mjhid.2019.052.

Texte intégral

Résumé :

Background: Vaccination for hepatitis B virus (HBV) after chemotherapy among pediatric patients with acute leukemia is still a debated issue. We investigated HBV immunity before and after chemotherapy and assessed immune response to re-vaccination after chemotherapy. Methods: We retrospectively analyzed data of children and adolescents aged <19 years requested for vaccination after chemotherapy for acute leukemia to evaluate hepatitis B surface antibody (HBsAb) status before and after chemotherapy and to identify factors related to HBsAb positivity after chemotherapy. Results: O

Styles APA, Harvard, Vancouver, ISO, etc.

6

Rice, W. G., and J. A. Turpin. "Virus-encoded Zinc Fingers as Targets for Antiviral Chemotherapy." Reviews in Medical Virology 6, no. 4 (1996): 187–99. http://dx.doi.org/10.1002/(sici)1099-1654(199612)6:4<187::aid-rmv176>3.0.co;2-f.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Wainberg, Mark A., Andre Dascal, and Jack Mendelson. "Anti-Retroviral Strategies for AIDS and Related Diseases." Canadian Journal of Infectious Diseases 2, no. 3 (1991): 121–28. http://dx.doi.org/10.1155/1991/487657.

Texte intégral

Résumé :

The replication cycle of human immunodeficiency virus type 1 (HIV-1) and other retroviruses consists of four stages: attachment of the virus to specific receptors on the cell surface; uncoating of the viral nucleic acid and conversion to DNA; production of viral RNA and proteins; and assembly and liberation of progeny virus from the cell. Each of these steps represents a potential target for antiviral chemotherapy. Combinations of drugs which act against different steps in the viral replication cycle might be expected to have synergistic potential. Zidovudine (AZT) is the most widely used drug

Styles APA, Harvard, Vancouver, ISO, etc.

8

FIELD, HUGH J. "The impact of drug resistance upon virus chemotherapy." Journal of Antimicrobial Chemotherapy 24, no. 1 (1989): 4–7. http://dx.doi.org/10.1093/jac/24.1.4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Benke, Ashwini Prashant, Ram Krishna, Kiran Khandagale, et al. "Efficient Elimination of Viruses from Garlic Using a Combination of Shoot Meristem Culture, Thermotherapy, and Chemical Treatment." Pathogens 12, no. 1 (2023): 129. http://dx.doi.org/10.3390/pathogens12010129.

Texte intégral

Résumé :

Garlic (Allium sativum L.) is a clonally propagated bulbous crop and can be infected by several viruses under field conditions. A virus complex reduces garlic yield and deteriorates the quality of the produce. In the present study, we aimed to eliminate Onion yellow dwarf virus (OYDV), Garlic common latent virus (GCLV), Shallot latent virus (SLV), and Allexiviruses from the infected crop using combination of meristem culture, thermotherapy, and chemotherapy. In this study, seven different treatments, namely shoot meristem culture, thermotherapy direct culture, chemotherapy direct culture, chem

Styles APA, Harvard, Vancouver, ISO, etc.

10

Dorobantu, Cristina M., Christian Harak, Rahel Klein та ін. "Tyrphostin AG1478 Inhibits Encephalomyocarditis Virus and Hepatitis C Virus by Targeting Phosphatidylinositol 4-Kinase IIIα". Antimicrobial Agents and Chemotherapy 60, № 10 (2016): 6402–6. http://dx.doi.org/10.1128/aac.01331-16.

Texte intégral

Résumé :

ABSTRACTEncephalomyocarditis virus (EMCV), like hepatitis C virus (HCV), requires phosphatidylinositol 4-kinase IIIα (PI4KA) for genome replication. Here, we demonstrate that tyrphostin AG1478, a known epidermal growth factor receptor (EGFR) inhibitor, also inhibits PI4KA activity, bothin vitroand in cells. AG1478 impaired replication of EMCV and HCV but not that of an EMCV mutant previously shown to escape PI4KA inhibition. This work uncovers novel cellular and antiviral properties of AG1478, a compound previously regarded only as a cancer chemotherapy agent.

Styles APA, Harvard, Vancouver, ISO, etc.

11

Roy, Biswajit G. "Potential of small-molecule fungal metabolites in antiviral chemotherapy." Antiviral Chemistry and Chemotherapy 25, no. 2 (2017): 20–52. http://dx.doi.org/10.1177/2040206617705500.

Texte intégral

Résumé :

Various viral diseases, such as acquired immunodeficiency syndrome, influenza, and hepatitis, have emerged as leading causes of human death worldwide. Scientific endeavor since invention of DNA-dependent RNA polymerase of pox virus in 1967 resulted in better understanding of virus replication and development of various novel therapeutic strategies. Despite considerable advancement in every facet of drug discovery process, development of commercially viable, safe, and effective drugs for these viruses still remains a big challenge. Decades of intense research yielded a handful of natural and sy

Styles APA, Harvard, Vancouver, ISO, etc.

12

Patel, R., and S. E. Barton. "Antiviral Chemotherapy in Genital Herpes Simplex Virus Infections." International Journal of STD & AIDS 6, no. 5 (1995): 320–28. http://dx.doi.org/10.1177/095646249500600503.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

De Clercq, Erik. "Acyclic Nucleoside Phosphonates in the Chemotherapy of DNA Virus and Retrovirus Infections." Intervirology 40, no. 5-6 (1997): 295–303. http://dx.doi.org/10.1159/000150563.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

14

Yeo, Winnie, Joyce L. Steinberg, John S. Tam, et al. "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy." Journal of Medical Virology 59, no. 3 (1999): 263–69. http://dx.doi.org/10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

15

Barsukova, E. N., I. V. Kim, and T. N. Сhekushkina. "IMPROVEMENT AND IN VITRO MICROPROPAGATION OF POTATO VARIETIES FOR DISEASE-FREE SEED GROWING." Far Eastern Agrarian Herald, no. 4 (2018): 20–26. https://doi.org/10.22450/1999-6837-2018-4-20-26.

Texte intégral

Résumé :

The quality of potato seed material is one of the main factors determining its yield. Under the long-term reproduction potato accumulates diseases, mostly viral. Viral diseases cause the decrease in yield 2-3 times, worsen the quality of tubers. It is possible to solve this problem by creating virusresistant varieties, as well as by switching seed production to a virus-free base (healthy basis). Creation of the virus – free collection under the in vitro conditions is the basis for the development of potato seed production in any region of the Russian Federation. In this regard, the purpose of

Styles APA, Harvard, Vancouver, ISO, etc.

16

Rollinson, E. A. "Prospects for Antiviral Chemotherapy in Veterinary Medicine: 2. Avian, Piscine, Canine, Porcine, Bovine and Equine Virus Diseases." Antiviral Chemistry and Chemotherapy 3, no. 6 (1992): 311–26. http://dx.doi.org/10.1177/095632029200300601.

Texte intégral

Résumé :

This paper, which is published in two parts, reviews the literature pertaining to antiviral chemotherapy of viruses of veterinary importance. While early reports in the 1970s referred to the chemotherapy of a number of different RNA and DNA viruses, there was considerable focus in the 1980s, initially on herpesviruses and latterly on retroviruses, and particularly in cats. Details are given of the successful treatments of FeLV and FIV, which have been used as animal models for HIV therapy. Therapy of equine, canine, bovine, porcine, avian, and fish diseases is also considered. The high costs o

Styles APA, Harvard, Vancouver, ISO, etc.

17

Tien Phat, Do, Pham Bich Ngoc, and Chu Hoang Ha. "Methods to manage, protect and improve plant virus resistance." Vietnam Journal of Biotechnology 19, no. 4 (2022): 607–18. http://dx.doi.org/10.15625/1811-4989/15584.

Texte intégral

Résumé :

Viral diseases caused severe damage for plant growth and development. Penetration and spread of viruses in the host plants dramatically reduce crop yield and quality. Due to the critical damages of viral diseases to agricultural production, different approaches and methods have been developed and utilized to manage, protect and improve plant virus resistance. Of which, conventional methods such as meristem culture, thermotherapy, cryotherapy as well as chemotherapy have been widely used and conducted effective results. Moreover, cross protection and gene pyramiding approaches have performed th

Styles APA, Harvard, Vancouver, ISO, etc.

18

Thackray, Alana M., and Hugh J. Field. "Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy." Antimicrobial Agents and Chemotherapy 44, no. 1 (2000): 97–102. http://dx.doi.org/10.1128/aac.44.1.97-102.2000.

Texte intégral

Résumé :

ABSTRACT Young adult mice were inoculated with herpes simplex virus type 2 (HSV-2) in the ear pinna. A relatively severe infection resulted, and 45% of the mice died by 11 days postinfection. Therapy at 1 mg/ml by means of the drinking water with either famciclovir for periods of 5 or 10 days or valaciclovir for 5, 10, 15, or 20 days decreased clinical signs and reduced mortality to 15% or less. Throughout a period of 27 days, mice were tested daily for the presence of infectious virus in the ear pinna, brain stem, and ipsilateral trigeminal ganglia. Virus was cleared from these tissues in sur

Styles APA, Harvard, Vancouver, ISO, etc.

19

Hirsch, M. S. "Chemotherapy of Human Immunodeficiency Virus Infections: Current Practice and Future Prospects." Journal of Infectious Diseases 161, no. 5 (1990): 845–57. http://dx.doi.org/10.1093/infdis/161.5.845.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Dylewski, J., and L. Thibert. "Failure of Tuberculosis Chemotherapy in a Human Immunodeficiency Virus-Infected Patient." Journal of Infectious Diseases 162, no. 3 (1990): 778–79. http://dx.doi.org/10.1093/infdis/162.3.778.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Henrich, Timothy J., Kristen S. Hobbs, Emily Hanhauser, et al. "Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy." Journal of Infectious Diseases 216, no. 2 (2017): 254–62. http://dx.doi.org/10.1093/infdis/jix265.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

Cingarlini, Sara. "Unusual Presentations for EBV and HHV8 Co-Infections: A Case Report and Review of Literature." Journal of Clinical Case Studies Reviews & Reports 5, no. 9 (2023): 1–6. http://dx.doi.org/10.47363/jccsr/2023(5)258.

Texte intégral

Résumé :

HHV-8 is known to be related to Kaposi sarcomas but can be responsible for other diseases such as Castleman’s disease (MCD) and primary effusion lymphoma (PEL). Epstein-Barr virus, on the other hand, is generally responsible for B-lineage lymphoproliferative diseases (LPD). In this case report we describe the case of a co-infection with HHV-8 and EBV with an unusual presentation. It is in fact a Kaposi sarcoma diagnosed in a heterosexual, immunocompetent and HIV-negative patient who initially presented with nodal disease only and a severe hemolytic anaemia. The same patient was also diagnosed

Styles APA, Harvard, Vancouver, ISO, etc.

23

Idilman, R., M. Arat, E. Soydan, et al. "Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies." Journal of Viral Hepatitis 11, no. 2 (2004): 141–47. http://dx.doi.org/10.1046/j.1365-2893.2003.00479.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

Ishii, T., M. Hosoya, S. Mori, S. Shigeta, and H. Suzuki. "Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis." Antimicrobial Agents and Chemotherapy 40, no. 1 (1996): 241–43. http://dx.doi.org/10.1128/aac.40.1.241.

Texte intégral

Résumé :

The ribavirin concentration in hamster brains was measured by a high-performance liquid chromatography (HPLC) system and a bioassay system. When ribavirin was administered intracranially at a dosage of 10 mg/kg of body weight per day for 10 days, a dosage which results in 100% survival of hamsters infected with subacute sclerosing panencephalitis (SSPE) virus and which inhibits the replication of SSPE virus in hamster brains, the ribavirin concentration in the brains estimated by HPLC and bioassay was kept higher than 50 micrograms/g for 10 days. The effective concentration in vivo corresponds

Styles APA, Harvard, Vancouver, ISO, etc.

25

Потапенко, Всеволод Геннадьевич, та М. М. Антонов. "Вторичный гемофагоцитарный синдром и хроническая активная болезнь, ассоциированные с вирусом Эпштейна—Барр (обзор литературы)". Clinical Oncohematology 18, № 3 (2025): 286–92. https://doi.org/10.21320/2500-2139-2025-18-3-286-292.

Texte intégral

Résumé :

Epstein-Barr virus (EBV) infection can cause secondary hemophagocytic syndrome and severe chronic active disease. The diseases are characterized by pathologic hyperergic reaction manifested by fever, cytopenia, and multiple organ failure. Cytostatic therapy reduces inflammatory response, allows for infection resolution, or stabilizes the patient before the next stage of treatment. This paper reviews current knowledge about diagnosis and treatment of EBV-associated diseases with the main focus on chemotherapy for EBV-associated secondary hemophagocytic syndrome and chronic active disease.

Styles APA, Harvard, Vancouver, ISO, etc.

26

Oketani, Makoto, Akio Ido, Hirofumi Uto, and Hirohito Tsubouchi. "Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy." Hepatology Research 42, no. 7 (2012): 627–36. http://dx.doi.org/10.1111/j.1872-034x.2012.00998.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Locasciulli, A., M. Santamaria, G. Masera, E. Schiavon, A. Alberti, and G. Realdi. "Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy." Journal of Medical Virology 15, no. 1 (1985): 29–33. http://dx.doi.org/10.1002/jmv.1890150105.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Yeo, Winnie, Paul K. S. Chan, Henry L. Y. Chan, Frankie K. F. Mo, and Philip J. Johnson. "Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis." Journal of Medical Virology 65, no. 3 (2001): 473–77. http://dx.doi.org/10.1002/jmv.2060.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

29

De Clercq, Erik. "Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections." International Journal of Antimicrobial Agents 7, no. 3 (1996): 193–202. http://dx.doi.org/10.1016/s0924-8579(96)00319-6.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

30

Ilyushina, Natalia A., Erich Hoffmann, Rachelle Salomon, Robert G. Webster, and Elena A. Govorkova. "Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice." Antiviral Therapy 12, no. 3 (2006): 363–70. http://dx.doi.org/10.1177/135965350701200302.

Texte intégral

Résumé :

Background The clinical management of H5N1 influenza virus infection in humans remains unclear. Combination chemotherapy with drugs that target different viral proteins might be more effective than monotherapy. Methods BALB/c mice were treated by oral gavage for 5 days with amantadine (1.5, 15 or 30 mg/kg/day) and oseltamivir (1 or 10 mg/kg/day) separately or in combination. Mice were challenged 24 h after initiation of treatment with 10 mouse 50% lethal doses of either amantadine-sensitive (having S31 in the M2 protein) or amantadine-resistant (having N31 in the M2 protein) recombinant A/Viet

Styles APA, Harvard, Vancouver, ISO, etc.

31

Zumla, A., and S. L. Croft. "Chemotherapy and immunity in opportunistic parasitic infections in AIDS." Parasitology 105, S1 (1992): S93—S101. http://dx.doi.org/10.1017/s0031182000075405.

Texte intégral

Résumé :

SUMMARYParasitic diseases are endemic in parts of the tropics, but there is no convincing evidence that their prevalence or incidence is increasing due to the HIV epidemic. Available scientific data on parasitic infections in patients with the Acquired Immunodeficiency Syndrome (AIDS) suggests a predominance of Pneumocystis carinii, Toxoplasma gondii and Cryptosporidium spp. For reasons which are unclear, parasitic infections such as Plasmodium falciparum, Strongyloides stercoralis and Entamoeba histolytica, where cell-mediated immune responses are also thought to be significant, do not appear

Styles APA, Harvard, Vancouver, ISO, etc.

32

Sjöberg, Anita Herrström, Liya Wang, and Staffan Eriksson. "Antiviral Guanosine Analogs as Substrates for Deoxyguanosine Kinase: Implications for Chemotherapy." Antimicrobial Agents and Chemotherapy 45, no. 3 (2001): 739–42. http://dx.doi.org/10.1128/aac.45.3.739-742.2001.

Texte intégral

Résumé :

ABSTRACT A highly active form of human recombinant deoxyguanosine kinase (dGK) phosphorylated purine nucleoside analogs active against cytomegalovirus, hepatitis B virus, and human immunodeficiency virus, such as penciclovir, 2′,3′-dideoxyguanosine and 3′-fluoro-2′,3′-dideoxyguanosine. The antiherpesvirus drug ganciclovir, which is also used in gene therapy, was a substrate for dGK, but with low efficiency. ATP and UTP were both good phosphate donors, with apparent Km values of 6 and 4 μM andV max values of 34 and 90 nmol of dGMP/mg of dGK/min, respectively. With a mixture of 5 mM ATP and 0.05

Styles APA, Harvard, Vancouver, ISO, etc.

33

Chen, Jungang, Samantha Kendrick, and Zhiqiang Qin. "Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas." Viruses 11, no. 12 (2019): 1161. http://dx.doi.org/10.3390/v11121161.

Texte intégral

Résumé :

Viral lymphomagenesis induced by infection with oncogenic viruses, such as Kaposi’s sarcoma associated herpesvirus (KSHV), Epstein–Barr virus (EBV) and human T-cell leukemia virus (HTLV-1), represents a group of aggressive malignancies with a diverse range of pathological features. Combined chemotherapy remains the standard of care for these virus-associated lymphomas; however, frequent chemoresistance is a barrier to achieving successful long-term disease-free survival. There is increasing evidence that indicates virus-associated lymphomas display more resistance to cytotoxic chemotherapeutic

Styles APA, Harvard, Vancouver, ISO, etc.

34

Zon, Robin T., and Michael N. Neuss. "ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases." Journal of Oncology Practice 6, no. 4 (2010): 193–94. http://dx.doi.org/10.1200/jop.777007.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

35

Yeo, Winnie, Paul K. S. Chan, Pun Hui, et al. "Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study." Journal of Medical Virology 70, no. 4 (2003): 553–61. http://dx.doi.org/10.1002/jmv.10430.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

KOTLYAR, V. K., S. V. FEDOROVICH, and O. L. SEGET. "IMPROVEMENT OF GRAPE CUTTINGS BY THERMOTHERAPY AGAINST GLRAV-3 VIRUS." Scientific Works of North Caucasian Federal Scientific Center of Horticulture Viticulture Wine-making 37 (September 2023): 107–10. http://dx.doi.org/10.30679/2587-9847-2023-37-107-110.

Texte intégral

Résumé :

GLRaV-3 is a systemic phloem virus, has been detected in almost all wine regions of the world and is responsible for significant economic damage. The use of healthy breeding material is crucial for the control of vine diseases caused by viruses, due to the lack of established treatment for viral diseases in the field conditions. In this study, we conducted a series of experiments on thermotherapy on grape cuttings that had passed the dormant period in order to determine the most effective mode of healing of grape cuttings from the GLRaV-3 virus. The data obtained by us in the course of this st

Styles APA, Harvard, Vancouver, ISO, etc.

37

Greiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.133.

Texte intégral

Résumé :

Abstract This review addresses the clinical presentation, pathology, and therapy of several uncommon lymphoid proliferations. Because these lymphoproliferations span the characteristics of reactive polymorphous proliferations to clonal malignant neoplasms, they are often difficult to diagnose and treat effectively. In Section I, Dr. Greiner describes the pathology of the spectrum of atypical lymphoid disorders including Castleman's disease, angioimmunoblastic lymphadenopathy, lymphadenopathy in autoimmune diseases, posttransplant lymphoproliferative disorders, and X-linked lymphoproliferative

Styles APA, Harvard, Vancouver, ISO, etc.

38

Greiner, Timothy, James O. Armitage, and Thomas G. Gross. "Atypical Lymphoproliferative Diseases." Hematology 2000, no. 1 (2000): 133–46. http://dx.doi.org/10.1182/asheducation.v2000.1.133.20000133.

Texte intégral

Résumé :

This review addresses the clinical presentation, pathology, and therapy of several uncommon lymphoid proliferations. Because these lymphoproliferations span the characteristics of reactive polymorphous proliferations to clonal malignant neoplasms, they are often difficult to diagnose and treat effectively.In Section I, Dr. Greiner describes the pathology of the spectrum of atypical lymphoid disorders including Castleman's disease, angioimmunoblastic lymphadenopathy, lymphadenopathy in autoimmune diseases, posttransplant lymphoproliferative disorders, and X-linked lymphoproliferative disorder.

Styles APA, Harvard, Vancouver, ISO, etc.

39

Korzh, Elena V. "Interstitial lung diseases in persons infected with human immunodeficiency virus." PULMONOLOGIYA 33, no. 6 (2023): 841–48. http://dx.doi.org/10.18093/0869-0189-2023-33-6-841-848.

Texte intégral

Résumé :

Diagnosis of interstitial lung diseases (ILD) in individuals infected with the human immunodeficiency virus (HIV) remains poorly understood.The purpose of the work was to demonstrate approaches to the diagnosis of ILD in HIV-infected patients with different levels of CD4 lymphocytes. An analysis of literature data and clinical observations of ILD in HIV-infected individuals (n = 2) whose CD4 lymphocyte count was 677 (37.5%) and 1 (0.21%) cells/μl are presented. The patients were observed and treated for a long time by pulmonology specialists, including anti-tuberculosis chemotherapy. The patie

Styles APA, Harvard, Vancouver, ISO, etc.

40

Polyakov, Yu Yu, E. A. Baryakh, E. N. Misyurina, et al. "Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2." Oncohematology 19, no. 2 (2024): 101–8. http://dx.doi.org/10.17650/1818-8346-2024-19-2-101-108.

Texte intégral

Résumé :

Treatment of immunocompromised patients with novel coronavirus infection (COVID-19) presents significant challenges. Currently, there are no unified approaches to the treatment of persistent COVID-19 in hematological malignancies. There is a need to develop recommendations for the management of such patients, chemotherapy protocols, as well as therapy for COVID-19 in case of SARS-CoV-2 virus persistence. Doctors are faced with cases of virus persistence, clinical manifestations during a long course of the infectious process and are not provided with methodological recommendations for patient s

Styles APA, Harvard, Vancouver, ISO, etc.

41

Islas-Muñoz, B., B. Méndez-Sotelo, J. Reyes-Pérez, M. Jiménez-de los Santos, R. Herrera-Goepfert, and P. Volkow-Fernández. "Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C." International Journal of STD & AIDS 31, no. 11 (2020): 1110–13. http://dx.doi.org/10.1177/0956462420943027.

Texte intégral

Résumé :

We present the case of a 28-year-old man with recently-diagnosed human immunodeficiency virus and hepatitis C virus infection. He developed obstructive cholangiopathy secondary to cytomegalovirus and Kaposi sarcoma, both diagnosed by endoscopic retrograde cholangiopancreatography and biopsies. He received antiretroviral therapy, chemotherapy and valganciclovir with full recovery.

Styles APA, Harvard, Vancouver, ISO, etc.

42

Uchiyama, Michihiro, Yotaro Tamai, and Takashi Ikeda. "Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma." International Journal of Infectious Diseases 14, no. 3 (2010): e265-e266. http://dx.doi.org/10.1016/j.ijid.2009.04.014.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Nowak, J. S., and D. Januszkiewicz. "CHEMOTHERAPY OF CHILDREN WITH LYMPHOPROLIFERATIVE DISEASES AS A RISK FACTOR FOR HEPATITIS C VIRUS INFECTION. 127." Pediatric Research 41, no. 5 (1997): 770. http://dx.doi.org/10.1203/00006450-199705000-00146.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Ramphal, Raveena, Ronald M. Grant, Biljana Dzolganovski, et al. "Herpes Simplex Virus in Febrile Neutropenic Children Undergoing Chemotherapy for Cancer." Pediatric Infectious Disease Journal 26, no. 8 (2007): 700–704. http://dx.doi.org/10.1097/inf.0b013e31805cdc11.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

45

Pham, Hoang. "Mathematical Modeling the Time-Delay Interactions between Tumor Viruses and the Immune System with the Effects of Chemotherapy and Autoimmune Diseases." Mathematics 10, no. 5 (2022): 756. http://dx.doi.org/10.3390/math10050756.

Texte intégral

Résumé :

The immune system is the body’s defense against pathogens, which are complex living organisms found in many parts in the body including organs, tissues, cells, molecules, and proteins. When the immune system works properly, it can recognize and kill the abnormal cells and the infected cells. Otherwise, it can attack the body’s healthy cells even if there is no invader. Many researchers have developed immunotherapy (or cancer vaccines) and have used chemotherapy for cancer treatment that can kill fast-growing cancer cells or at least slow down tumor growth. However, chemotherapy drugs travel th

Styles APA, Harvard, Vancouver, ISO, etc.

46

Nishida, Tsutomu, Naoki Hiramatsu, Masao Mizuki, et al. "Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic." Hepatology Research 43, no. 4 (2012): 339–46. http://dx.doi.org/10.1111/j.1872-034x.2012.01073.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

47

Shahgolzari, Mehdi, Srividhya Venkataraman, Anne Osano, Paul Achile Akpa, and Kathleen Hefferon. "Plant Virus Nanoparticles Combat Cancer." Vaccines 11, no. 8 (2023): 1278. http://dx.doi.org/10.3390/vaccines11081278.

Texte intégral

Résumé :

Plant virus nanoparticles (PVNPs) have garnered considerable interest as a promising nanotechnology approach to combat cancer. Owing to their biocompatibility, stability, and adjustable surface functionality, PVNPs hold tremendous potential for both therapeutic and imaging applications. The versatility of PVNPs is evident from their ability to be tailored to transport a range of therapeutic agents, including chemotherapy drugs, siRNA, and immunomodulators, thereby facilitating targeted delivery to the tumor microenvironment (TME). Furthermore, PVNPs may be customized with targeting ligands to

Styles APA, Harvard, Vancouver, ISO, etc.

48

Castelli, Roberto, Riccardo Schiavon, Carlo Preti, and Laurenzia Ferraris. "HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy." Cardiovascular & Hematological Disorders-Drug Targets 20, no. 3 (2020): 175–80. http://dx.doi.org/10.2174/1871529x20666200415121009.

Texte intégral

Résumé :

HIV-positive patients have a 60- to 200-fold increased incidence of Non-Hodgkin Lymphomas (NHL) because of their impaired cellular immunity. Some NHL are considered Acquired Immunodeficiency Syndrome (AIDS) defining conditions. Diffuse large B-cell Lymphoma (DLBC) and Burkitt Lymphoma (BL) are the most commonly observed, whereas Primary Effusion Lymphoma (PEL), Central Nervous System Lymphomas (PCNSL), Plasmablastic Lymphoma (PBL) and classic Hodgkin Lymphoma (HL) are far less frequent. Multicentric Castleman disease (MCD) is an aggressive lymphoproliferative disorder highly prevalent in HIV-p

Styles APA, Harvard, Vancouver, ISO, etc.

49

Li, Shu, Xiao-Yu Liu, Qiu Pan, et al. "Hepatitis C Virus-Induced FUT8 Causes 5-FU Drug Resistance in Human Hepatoma Huh7.5.1 Cells." Viruses 11, no. 4 (2019): 378. http://dx.doi.org/10.3390/v11040378.

Texte intégral

Résumé :

Hepatitis C virus (HCV) is a major cause of human chronic liver disease and hepatocellular carcinoma. Our recent studies showed that α1,6-fucosyltransferase (FUT8), a key glycosyltransferase, was the most up-regulated glycosyltransferase after the HCV infection of human hepatocellular carcinoma Huh7.5.1 cells. Here, we further studied the effects and possible mechanism of FUT8 on the proliferation of HCV and chemotherapy-resistance of HCV-infected Huh7.5.1 cells. The effects of FUT8 on the proliferation and drug resistance of HCV-infected Huh7.5.1 cells were analyzed by flow cytometry analysis

Styles APA, Harvard, Vancouver, ISO, etc.

50

Cesaro, Simone, Mareva Giacchino, Francesca Fioredda, et al. "Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients." BioMed Research International 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/707691.

Texte intégral

Résumé :

Objective.Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children.Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematology Oncology (AIEOP) addressed this issue by guidelines on vaccinations in paediatric cancer patients. The literature published between 1980 and 2013 was reviewed.Results and Conclusion. During intensive chemotherapy, vaccination turned out to be effective for hepatitis A and B, whilst vaccinations wi

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!